Skip to content
Educational information only. Not medical advice. We sell nothing and take no affiliate money.
By /
Peptide extractLimited humanNot FDA approved

Thymalin

Thymalin (calf thymus peptide extract)

Last reviewed October 27, 2026 · 10 sources · Written for general readers · Compare with another compound →

The bottom line

Thymalin is a mix of peptides taken from calf thymus and registered as a medicine in Russia.[1][2] Claims that it restores immunity, prevents infections and extends life rest on older, poorly described studies run almost entirely by the group that developed it, and no independent placebo controlled trial exists.[3] It has no US approval and is not on FDA's compounding lists.[4]

Where the evidence stands

What it is

Thymalin is not one single peptide. It is a complex of small proteins extracted from the thymus glands of calves and developed as a treatment for weak immune function.[1][5]

Its developers call it a peptide bioregulator, their term for a peptide meant to restore the normal work of a specific organ.[3] In Russia it has a Ministry of Health registration dated 2010 and has long been used for conditions with poor immune function.[2]

Because it is an extract, its makeup cannot be written as one formula. Researchers later isolated a two amino acid piece from it, which became a separate synthetic drug called Thymogen.[1]

Name
Thymalin (Thymalin (calf thymus peptide extract))
Other names
thymus polypeptide complex, Timalin
Type
Peptide extract

How it works

The idea is that thymus peptides help an aging or weakened immune system work more like a healthy one.

  • In lab work, thymalin and its pieces pushed immature immune cells to develop into T cells and changed immune signals such as interleukin 2 and interferon.[1]
  • One cell study reported that thymalin shifted human blood stem cell markers toward those of mature T cells.[6]
  • The developers also report that it helps normalize blood clotting in some illnesses.[5]

These mechanism claims come almost entirely from one research group and have not been widely confirmed by others.

What the research shows

We keep animal and human evidence apart. A result in animals is a reason to study something in people, not proof that it works in people.

Animal and lab studies

Old animal studies, mostly from the developers

  • Studies in mice going back to the early 1980s looked at how thymalin affects the size and function of the thymus.[9]
  • Reviews by the developers describe animal studies suggesting restored immune function in older animals.[5]
  • In lab cultures of human blood stem cells, thymalin shifted cell markers toward mature T cells.[6]

Limit: The animal work is old, small and rarely repeated by independent labs.

Human studies

Small, older studies from one group

  • Older adults (2003): 266 people were followed for 6 to 8 years. The developers reported fewer respiratory infections and roughly half the death rate with thymalin compared with controls.[3]
  • That paper's summary does not explain how people were placed into groups, how they were given the extract, or what side effects occurred.[3]
  • Severe COVID-19 (2022): a look back study compared standard care, standard care plus tocilizumab, and standard care plus thymalin. Hospital deaths were about 41 percent, 28 percent and 21 percent. Lymphocytes doubled and clotting markers such as D dimer fell in the thymalin group. Groups were not randomized and sizes were not given in the summary.[7]
  • COVID-19 (2021): a report from the developers said adding thymalin sped the fall of inflammation markers and D dimer, but gave no patient numbers or side effect data.[8]
  • Reviews by the same group describe use in lung abscess and pneumonia with better inflammation and clotting markers, but give few study details.[5][2]
  • We found no large, independent, placebo controlled trial of thymalin.[3]

Limit: Nearly every human study comes from the developers or their colleagues, and none was a well described placebo controlled trial.

Claims check

The most common claims about this compound, and what studies actually found. Verdicts rate the evidence, not whether you should use it.

Restores a weak or aging immune system

Mixed results

The developers report improved immune cell counts and markers in older people and in various illnesses, but give few study details.[5][3] In a look back at severe COVID-19 patients, those given thymalin had lymphocyte counts that doubled.[7] Independent controlled trials measuring whether people actually get fewer illnesses are missing.

Extends lifespan and slows aging

Mixed results

A 2003 paper by the developers followed 266 older adults for 6 to 8 years and reported roughly half the death rate in people given thymalin compared with controls.[3] The summary does not explain how people were put into groups, which makes such a large effect hard to trust, and no one else has repeated it.

Prevents respiratory infections

Mixed results

The same 2003 study reported fewer respiratory infections in older adults given thymalin.[3] Reviews by the developers describe use in lung abscess and pneumonia with better inflammation and clotting markers, without full study details.[5][2]

Treats COVID-19

Mixed results

In a Russian look back study of severe COVID-19 in middle aged and older patients, hospital deaths were about 21 percent with thymalin added, versus about 41 percent with standard care alone, and groups were not randomly assigned.[7] Another report said thymalin sped the fall of inflammation and clotting markers but gave no patient numbers.[8]

Known risks and side effects

  • An animal tissue mixture. Thymalin is extracted from calf thymus, so it is a mixture rather than one defined molecule, and batches can vary.[1]
  • Side effects are poorly described. The study summaries we reviewed focus on benefits and say little or nothing about side effects, so the true risk is unclear.[3][5][7]
  • Evidence from its own developers. Most claims trace back to papers by the group that created the drug, which raises the chance of bias.[1][3][5]
  • Unregulated online products. Thymalin is not on FDA's compounding category lists, so vials sold online in the US have had no FDA review of purity or sterility.[4]

Regulatory status

Today: Thymalin is registered as a medicine in Russia.[2] It does not appear on FDA's compounding category lists; thymulin acetate, a different thymus peptide, sits in category 3 for lack of supporting information.[4] It is not named on WADA's 2026 Prohibited List.[10]

  1. Russia's Ministry of Health issued the thymalin registration cited by its developers.[2]

Sources

  1. Morozov VG, Khavinson VK. Natural and synthetic thymic peptides as therapeutics for immune dysfunction. Int J Immunopharmacol. 1997;19(9-10):501-505. PMID 9637345
  2. Khavinson V, Linkova N, Dyatlova A, Kuznik B, Umnov R. Peptides: Prospects for Use in the Treatment of COVID-19. Molecules. 2020;25(19):4389. PMID 32987757
  3. Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-240. PMID 14523363
  4. U.S. Food and Drug Administration. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act (category lists). Updated May 14, 2026. FDA 503A category lists
  5. Khavinson VKh, Linkova NS, Chalisova NI, et al. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. Biol Bull Rev. 2021;11(4):377-382. DOI 10.1134/S2079086421040046
  6. Khavinson VK, Linkova NS, Kvetnoy IM, et al. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bull Exp Biol Med. 2020;170(1):118-122. PMID 33237528
  7. Kuznik BI, Shapovalov KG, Smolyakov YN, et al. Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin. Adv Gerontol. 2022;35(3):368-374. Article in Russian. PMID 36169363
  8. Khavinson VK, Kuznik BI, Trofimova SV, et al. Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19. Stem Cell Rev Rep. 2021;17(1):285-290. PMID 33575961
  9. Khmel'nitskii OK, Grintsevich II, Morozov VG. Effect of thymalin on thymus morphology and function in mice. Bull Exp Biol Med. 1982;94(3):1304-1307. DOI 10.1007/BF00835654
  10. World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. Effective 1 January 2026. WADA 2026 List
Medical disclaimer

This page is educational information only. It is not medical advice and does not replace care from a licensed medical provider. Do not use this page to decide whether to take any substance. Talk to a licensed medical provider first.

Found an error or a newer study? We correct pages fast.

Report a correction →
Scroll to Top